C/A
0001620704
XXXXXXXX
020-34208
LIVE
false
false
false
false
Amendment to add 2023 Audited financials, and increase the raise limit to $5,000,000.
MED-X, INC.
Corporation
NV
02-24-2014
8236 REMMET AVE.
CANOGA PARK
CA
91304
https://medx-rx.com
N
DEALMAKER SECURITIES LLC
0001872856
008-70756
000315324
The Company is offering securities under Regulation CF, through Intermediary. Intermediary will receive cash compensation equal to 8.5% of the value of the securities sold through Regulation CF, fixed fees of $32,500 and a monthly fee of $2,000.
$0
Common Stock
1666666
3.00000
4998.00
Y
Other
At Company's discretion
4999998.00
05-27-2025
17.00
1345328.00
2102959.00
65747.00
209472.00
50105.00
65373.00
520291.00
548331.00
0.00
0.00
1894784.00
1852775.00
1641617.00
1570977.00
0.00
0.00
6478496.00
7338431.00
AL
AK
AZ
AR
CA
CO
CT
DE
DC
FL
GA
HI
ID
IL
IN
IA
KS
KY
LA
ME
MD
MA
MI
MN
MS
MO
MT
NE
NV
NH
NJ
NM
NY
NC
ND
OH
OK
OR
PA
PR
RI
SC
SD
TN
TX
UT
VT
VA
WA
WV
WI
WY
A0
A1
A2
A3
A4
A5
A6
A7
A8
A9
B0
Z4
MED-X, INC.
/s/ Matthew Mills
Chief Executive Officer
/s/ Matthew Mills
Chief Executive Officer
09-26-2024